by GlobeNewsWire | Dec 15, 2015 | Globe Newswire
NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) — Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive, and eating disorders, announced today that it has received a...
by editor | Jan 4, 2012 | Latest Spotlights
Dallas, Texas – The StockGuru Spotlight – On Tuesday after market close, Lightlake Therapeutics Inc. (OTCBB: LLTP) announced that the Company is seeking to collaborate with Europe’s largest center for research and post-graduate education in...
by editor | May 19, 2011 | Latest Spotlights
DALLAS, TEXAS : StockGuru announces that Lightlake Therapeutics (OTCBB: LLTP) is in the StockGuru Spotlight. Lightlake Therapeutics is a Biopharmaceutical Company aiming to build a solid platform of pharmacological treatments based on its expertise using opioid...